LS
Leelyn Smith Portfolio holdings
AUM
$822M
Turnover
11.52%
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Avg Time Held
0.3
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$24.2M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.84M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$2.46M |
| 4 |
ExxonMobil
XOM
|
+$2.14M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.22M |
| 2 |
Microsoft
MSFT
|
+$2.06M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.93M |
| 4 |
Blackrock
BLK
|
+$1.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 53.95% |
| 2 | Technology | 9.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Industrials | 5.97% |
| 5 | Consumer Staples | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.4B
| $240K | 0.1% |
4,086
-848
| -17% | -$49.5K |
2019 Q4
2 quarters
|
|
102
iShares Core US Aggregate Bond ETF
AGG
$137B
| $236K | 0.1% |
1,995
-24
| -1% | -$2.81K |
2019 Q4
2 quarters
|
|
103
Thermo Fisher Scientific
TMO
$249B
| $224K | 0.09% |
619
-197
| -24% | -$66K |
2019 Q4
2 quarters
|
|
104
State Street Financial Select Sector SPDR ETF
XLF
$50.7B
| $221K | 0.09% |
+9,543
| New | +$217K |
2020 Q2
0 quarters
|
|
105
T-Mobile US
TMUS
$169B
| $219K | 0.09% |
2,105
| – | – |
2020 Q1
1 quarter
|
|
106
DELISTED
Comerica
CMA
| $212K | 0.09% |
5,559
+132
| +2% | +$4.6K |
2019 Q4
2 quarters
|
|
107
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
| $207K | 0.09% |
4,119
-6,545
| -61% | -$325K |
2019 Q4
2 quarters
|
|
108
iShares Silver Trust
SLV
$27B
| $204K | 0.08% |
12,004
| – | – |
2020 Q1
1 quarter
|
|
109
Waste Management
WM
$86.2B
| $189K | 0.08% |
1,785
-344
| -16% | -$34.7K |
2019 Q4
2 quarters
|
|
110
Merck
MRK
$364B
| $182K | 0.08% |
2,471
-124
| -5% | -$9.34K |
2019 Q4
2 quarters
|
|
111
iShares S&P 500 Growth ETF
IVW
$78.3B
| $175K | 0.07% |
3,368
-404
| -11% | -$19.4K |
2020 Q1
1 quarter
|
|
112
Prologis
PLD
$124B
| $174K | 0.07% |
1,866
| – | – |
2019 Q4
2 quarters
|
|
113
Costco
COST
$435B
| $172K | 0.07% |
568
| – | – |
2019 Q4
2 quarters
|
|
114
Xcel Energy
XEL
$47.1B
| $169K | 0.07% |
2,705
+180
| +7% | +$11.3K |
2019 Q4
2 quarters
|
|
115
Automatic Data Processing
ADP
$111B
| $168K | 0.07% |
1,132
| – | – |
2019 Q4
2 quarters
|
|
|
116
Blackrock
BLK
$166B
| $168K | 0.07% |
309
-2,638
| -90% | -$1.33M |
2019 Q4
2 quarters
|
|
117
Crown Castle
CCI
$33.8B
| $162K | 0.07% |
970
| – | – |
2019 Q4
2 quarters
|
|
118
CME Group
CME
$103B
| $161K | 0.07% |
990
| – | – |
2019 Q4
2 quarters
|
|
119
Zoetis
ZTS
$31.1B
| $157K | 0.06% |
1,145
| – | – |
2019 Q4
2 quarters
|
|
120
Danaher
DHR
$158B
| $152K | 0.06% |
968
-33
| -3% | -$4.74K |
2020 Q1
1 quarter
|
|
121
Vanguard Intermediate-Term Treasury ETF
VGIT
$39.8B
| $151K | 0.06% |
2,137
-2,573
| -55% | -$181K |
2019 Q4
2 quarters
|
|
122
JPMorgan Chase
JPM
$890B
| $148K | 0.06% |
1,573
| – | – |
2019 Q4
2 quarters
|
|
123
Paychex
PAYX
$38.6B
| $144K | 0.06% |
1,900
| – | – |
2019 Q4
2 quarters
|
|
124
Mid-America Apartment Communities
MAA
$13.4B
| $141K | 0.06% |
1,230
+150
| +14% | +$16.9K |
2019 Q4
2 quarters
|
|
125
DELISTED
Avangrid, Inc.
AGR
| $141K | 0.06% |
3,365
+370
| +12% | +$15.9K |
2019 Q4
2 quarters
|
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q2 2020 Portfolio in Review
As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
By sector, the portfolio is most concentrated in Miscellaneous at 54% of assets, up from 53% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.
- Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
- Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
- Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
- Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
- Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
- Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
- Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.
Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.